The FY26 budget is expected to be even tighter, with a lower fiscal deficit target. The government surprised everyone by not announcing any new social schemes or expanding existing ones. Allocation for popular social schemes like MNREGA and Jal Jeevan Mission remains unchanged. The budget focuses on boosting the investment cycle, with a significant increase in government capex, particularly on infrastructure projects. The tight fiscal situation may lead to lower interest rates and the possibility of policy rate cuts.
Biocon shares rise 2% on 10-year Pertuzumab supply deal for breast cancer therapy in Brazil
Biocon shares rose after the company secured a 10-year Pertuzumab supply contract in Brazil. The consortium with Bahiafarma and Bionovis received full allocation under the
September 8, 2026